OptiBiotix Health Plc (AIM:OPTI)
London · Delayed Price · Currency is GBP · Price in GBX 6.35
-0.10 (-1.55%)
Jul 6, 2026, 1:34 PM GMT
OptiBiotix Health Market Cap
OptiBiotix Health has a market cap or net worth of 6.66 million as of July 6, 2026. Its market cap has decreased by -43.30% in one year.
Market Cap
6.66M
Enterprise Value
5.63M
Revenue
1.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.35
Market Cap Chart
Since August 5, 2014, OptiBiotix Health's market cap has increased from 6.46M to 6.66M, an increase of 3.17%. That is a compound annual growth rate of 0.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 6.66M | -4.44% |
| Dec 31, 2025 | 6.97M | -60.45% |
| Dec 31, 2024 | 17.63M | -27.73% |
| Dec 29, 2023 | 24.39M | 101.89% |
| Dec 30, 2022 | 12.08M | -70.13% |
| Dec 31, 2021 | 40.45M | -20.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptamer Group | 16.41M |
| Fusion Antibodies | 15.00M |
| Palatin Technologies | 14.43M |
| Genflow Biosciences | 11.61M |
| Cizzle Biotechnology Holdings | 10.62M |
| CRISM Therapeutics | 5.69M |
| Thalia Therapeutics | 5.41M |
| Oxford BioDynamics | 4.72M |